Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Amyloid Imaging in MEMENTO
NCT02164643Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jun 2014
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Florbetapir, flutemetamol in Alzheimer's disease (AD), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Jun 2014; status: completed.
02
Drugs
Florbetapirflutemetamol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02164643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02164643.